Tatton Consulting supported Liverpool-based needle-free drug delivery company Medicsen in its successful application to Innovate UK Smart Grants: September 2023, which was awarded £347,550 by Innovate UK for the project Development the first needle-free, cannula-free, wearable drug delivery technology for large molecule medicines.
About the funded R&D project
Development of the first needle-free, cannula-free wearable drug delivery device. Removing both the needle and the cannula changes the adherence profile for conditions requiring frequent self-administration, where injection burden is a recognised driver of patients not following treatment.
Award details
- Grant awarded: £347,550
- Competition: Innovate UK Smart Grants: September 2023
- Competition year: 2023/24
- Project: Development the first needle-free, cannula-free, wearable drug delivery technology for large molecule medicines
- Sector: Drug delivery / medical devices
- UKRI project record: Gateway to Research, project 10112809
- Dataset: Innovate UK funded projects, published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title above are taken from UKRI’s published record for this project.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
